Bath Natalie M, Williams Daniel H, Sollinger Hans W, Redfield Robert R
Division of Transplant Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
J Rare Dis Res Treat. 2018;3(4):1-3. doi: 10.29245/2572-9411/2018/4.1169.
Loin Pain Hematuria Syndrome (LPHS) remains a rare disease but has a significant impact on those affected by it. Patients diagnosed with LPHS experience severe, constant or intermittent flank pain that radiates to the groin and may be exacerbated even by a gentle touch. These patients often require significant narcotic regimens for pain control and are unable to maintain a functional lifestyle. Previously, diagnosis has been made based on clinical presentation. One treatment for this syndrome is renal autotransplant; however, success rates are varied. Therefore, patient selection for this procedure is important. We have developed the UW-LPHS test as a diagnostic maneuver in order to determine which patients with LPHS would benefit from renal autotransplant. To perform this diagnostic test, bupivacaine is instilled into the ureter on the affected side and left to dwell. Patients who experience pain relief following this test are deemed to benefit from renal autotransplant. Here we describe this novel diagnostic test and initial success rates following renal autotransplant.
腰背痛血尿综合征(LPHS)仍然是一种罕见疾病,但对受其影响的患者有重大影响。被诊断为LPHS的患者会经历严重的、持续或间歇性的侧腹疼痛,疼痛会放射至腹股沟,甚至轻轻触碰也可能会加重疼痛。这些患者通常需要大量的麻醉药物来控制疼痛,并且无法维持正常的生活方式。以前,诊断是基于临床表现做出的。这种综合征的一种治疗方法是自体肾移植;然而,成功率各不相同。因此,选择合适的患者进行该手术很重要。我们开发了UW-LPHS测试作为一种诊断手段,以确定哪些LPHS患者将从自体肾移植中受益。为了进行这项诊断测试,将布比卡因注入患侧输尿管并留置。在此测试后疼痛缓解的患者被认为将从自体肾移植中受益。在这里,我们描述这种新型诊断测试以及自体肾移植后的初步成功率。